OMA Guidelines Bundle

Obesity Pharmacotherapy - OMA Obesity Algorithm 2023

Obesity Medicine Association OMA GUIDELINES App Bundle brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1349812

Contents of this Issue

Navigation

Page 20 of 29

21 TOP 10 TAKEAWAY MESSAGES: Supplements and OTC Therapies 1. Prescription drugs are a therapeutic medicine intended for the diagnosis, cure, mitigation, treatment or prevention of disease. Their approval and marketing is overseen by the U.S. Food and Drug Administration. 2. OTC medications are drugs the FDA considers safe and effective, but do not require a prescription by health professionals. Their approval via the FDA involves an OTC drug monograph regulatory process, and their marketing is overseen by the Federal Trade Commission. 3. Supplements are substances taken in addition to dietary intake (e.g., vitamins, herbs, botanicals, minerals and amino acids). The FDA does not approve supplements, since they are considered a food and not a drug. 4. Supplements are not permitted to be marketed for the purpose of treating, diagnosing, preventing, or curing diseases. 5. Functional Foods are nutrients with potentially favorable effects beyond basic nutrition (e.g., oatmeal may lower cholesterol). 6. Herbal and dietary supplements are a common cause of hepatotoxicity (e.g., anabolic steroids and green tea extracts), especially multi-ingredient nutritional supplements. 7. Most dietary supplements have limited to no consistent data to support long-term weight loss efficacy and safety and have the potential for adverse interactions when used as supplements to drugs. 8. Some weight loss supplements continue to be marketed, even when banned by the FDA due to adverse effects. 9. Patients should be advised of the limited evidence supporting the efficacy and safety of many supplements and the lack of oversight by government agencies regarding the claims made about such supplements. 10. Human chorionic gonadotropin (HCG) is not effective for weight loss beyond hypocaloric intake. The FDA requires clinicians and facilities that market HCG for weight loss to post a disclaimer that "There is no substantial evidence that HCG increases weight loss beyond that resulting from caloric restriction, that it causes a more attractive or normal distribution of fat, or that it decreases the hunger and discomfort associated with calorie restrictive diets."

Articles in this issue

Archives of this issue

view archives of OMA Guidelines Bundle - Obesity Pharmacotherapy - OMA Obesity Algorithm 2023